Start | Grid View | Browse by Day OR Group/Topical | Author Index | Keyword Index | Personal Scheduler

Crystallization of Pharmaceutical and Biological Molecules I

Monday, October 17, 2011: 8:30 AM
202 B (Minneapolis Convention Center)

Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.


Sponsor:
Crystallization and Evaporation
Co-Sponsor(s):
Pharmaceuticals (15b)


Chair:
Marina Tsianou
Email: mtsianou@eng.buffalo.edu

Co-Chair:
Christopher L. Burcham
Email: cburcham@lilly.com



8:30 AM
(20a) The Polymorphs of ROY: Application of Crystal Structure Prediction Techniques
Manolis Vasileiadis, Andrei V. Kazantsev, Panagiotis (Panos) G. Karamertzanis, Claire S. Adjiman and Constantinos C. Pantelides


8:55 AM
(20b) Spiral Growth Model for Organic Crystals of Real Complexity: How to Account for Unstable Spiral Edges
Zubin B. Kuvadia and Michael F. Doherty


9:20 AM
(20c) Modeling of Morphology Transformations In Crystalline Materials: A Generalized Framework
Meenesh R. Singh, Christian Borchert, Kai Sundmacher and Dorwaiswami Ramkrishna


9:45 AM
(20d) Microfluidic Platform for Evaporation-Based Solid Form Screening of Pharmaceutical Compounds
Sachit Goyal, Michael R. Thorson, Araz G. Zarkhah, Yuchuan Gong, Geoff G.Z. Zhang, Charles F. Zukoski and Paul J.A. Kenis


10:10 AM
(20e) Microfluidic Platforms for Crystallization Screening and In Situ Phasing & Structure Determination of Proteins
Sudipto Guha, Sarah L. Perry, Ashtamurthy Pawate, Satish K. Nair and Paul J. A. Kenis


10:35 AM
(20f) Microfluidic Platforms for In Situ Crystallographic Analysis
Sarah L. Perry, Sudipto Guha, Ashtamurthy Pawate, Robert B. Gennis, Zhong Ren and Paul J.A. Kenis
See more of this Group/Topical: Separations Division
<< Previous Session | Next Session >>